Comparative Cardiovascular Risks of Febuxostat and Allopurinol in Patients with Diabetes Mellitus and Chronic Kidney Disease

Hsin Hsiang Huang; Yun-Yi Chen; Yu-Wei Fang; Hung-Hsiang Liou; Jing-Tong Wang; Ming-Hsein Tsai

doi:10.12659/MSM.944314

12 June 2024 : Database Analysis

Comparative Cardiovascular Risks of Febuxostat and Allopurinol in Patients with Diabetes Mellitus and Chronic Kidney Disease

Hsin Hsiang Huang^1DE, Yun-Yi Chen^23BCD, Yu-Wei Fang^14ADG, Hung-Hsiang Liou^5AD, Jing-Tong Wang^1B, Ming-Hsein Tsai^14ADE*

DOI: 10.12659/MSM.944314

Med Sci Monit 2024; 30:e944314

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 2 Diagnosis date and Index date sequence. The software used for creation of the figure: Draw.io 24.10 JGraph Ltd, Artisans’ House, 7 Queensbridge, NN4 7BF, Northampton, England.

Back to the Article

Comparative Cardiovascular Risks of Febuxostat and Allopurinol in Patients with Diabetes Mellitus and Chronic Kidney Disease

Your Privacy